Cumulative incidence and risk factors of creatine kinase elevation associated with telbivudine
作者： Li Chen , Cai Cheng , Bicui Chen , Yue Zhao , Jiming Zhang
DOI: 10.1007/S00228-015-1978-9
关键词: Incidence (epidemiology) 、 Telbivudine 、 Internal medicine 、 Young adult 、 Gastroenterology 、 Renal function 、 Sex factors 、 Creatine kinase 、 Pharmacology toxicology 、 Cumulative incidence 、 Medicine 、 Endocrinology
摘要: Purpose An increasing number of studies are reporting a high frequency creatine kinase (CK) elevation during telbivudine therapy; however, few reports have focused on the cumulative incidence and risk factors CK elevation. This study was performed to investigate in Chinese patients treated with telbivudine.
springer.com
sci-hub.se 参考文章(36)
Maria Lorena Abate, Gian Paolo Caviglia, Antonina Smedile, R Pellicano, Chronic hepatitis B therapy: available drugs and treatment guidelines. Minerva gastroenterologica e dietologica. ,vol. 61, pp. 61- 70 ,(2015)
A Eliakim, D Nemet, José Oliveira, S Ben-Zaken, Y Meckel, José Alberto Duarte, C Yamin, Genetic aspects of exercise and rhabdomyolysis. Pediatric endocrinology reviews. ,vol. 11, pp. 400- 408 ,(2014)
S. W. Lee, J. H. Jang, B. J. Kim, Dysphagia could be the first presenting symptom of telbivudine-induced myopathy. Internal Medicine Journal. ,vol. 43, pp. 1048- 1049 ,(2013) , 10.1111/IMJ.12237
Edward J. Gane, Yuming Wang, Yun-Fan Liaw, JinLin Hou, Satawat Thongsawat, MoBin Wan, Young M. Moon, JiDong Jia, You C. Chao, Junqi Niu, Nancy Leung, Didier Samuel, Chao Wei Hsu, Weibin Bao, Patricia Lopez, Claudio Avila, Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Liver International. ,vol. 31, pp. 676- 684 ,(2011) , 10.1111/J.1478-3231.2011.02490.X
Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han, Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B. Clinical and molecular hepatology. ,vol. 19, pp. 82- 86 ,(2013) , 10.3350/CMH.2013.19.1.82
Shuangsuo Dang, Ning Gao, Xin Zhang, Xiaoli Jia, Rhabdomyolysis in a 48-Year-Old Man With Hepatitis B-Induced Cirrhosis The American Journal of the Medical Sciences. ,vol. 342, pp. 73- 75 ,(2011) , 10.1097/MAJ.0B013E31821A520E
Matthijs C. Brouwer, Arie van der Ende, Frank Baas, Diederik van de Beek, Genetic variation in GLCCI1 and dexamethasone in bacterial meningitis Journal of Infection. ,vol. 65, pp. 465- 467 ,(2012) , 10.1016/J.JINF.2012.07.001
Patricia A. Deuster, Carmen L. Contreras-Sesvold, Francis G. O’Connor, William W. Campbell, Kimbra Kenney, John F. Capacchione, Mark E. Landau, Sheila M. Muldoon, Elisabeth J. Rushing, Yuval Heled, Genetic polymorphisms associated with exertional rhabdomyolysis European Journal of Applied Physiology. ,vol. 113, pp. 1997- 2004 ,(2013) , 10.1007/S00421-013-2622-Y
Min Wang, Yuwei Da, Haodong Cai, Yan Lu, Liyong Wu, Jianping Jia, Telbivudine myopathy in a patient with chronic hepatitis B. International Journal of Clinical Pharmacy. ,vol. 34, pp. 422- 425 ,(2012) , 10.1007/S11096-012-9633-3
Y. Wang, S. Thongsawat, E. J. Gane, Y.‐F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski, N. V. Naoumov, Efficacy and safety of continuous 4‐year telbivudine treatment in patients with chronic hepatitis B Journal of Viral Hepatitis. ,vol. 20, ,(2013) , 10.1111/JVH.12025